“…They have subsequently written an expert opinion piece focusing on the use of protein crystals for the delivery of biopharmaceuticals, which describes the benefits, challenges, and techniques associated with this technology (Basu et al, ). In addition to this work, experimental (Falkner et al, ; Hebel, Huber, Stanislawski, & Hekmat, ; Hekmat, ; Martin & Zilm, ) and computational (Shi, Mhaskar, El‐Farra, & Christofides, ; J. J. Liu, Ma, Hu, & Wang, , ; Nayhouse, Sang‐Il Kwon, Christofides, & Orkoulas, ; J. J. Liu, Hu, & Wang, ; Joseph Sang‐Il Kwon, Nayhouse, Christofides, & Orkoulas, , , ) studies have characterized batch crystallization techniques for the generation of monodisperse sub‐micron protein crystals of specific morphologies in the interest of industrial scale pharmaceutical formulations and drug delivery. We also note that microcrystalline suspensions offer potential advantages in terms of shelf‐stability (Shenoy et al, ) and decreased viscosity which could enable delivery via smaller needles (Basu et al, ).…”